To Be Discontinued Capsule Cardiovascular
Phenoxybenzamine Hydrochlori · 284 days since initial FDA posting
FDA lists Phenoxybenzamine Hydrochlori as To Be Discontinued (Advanz Pharma (US) Corp.).
No availability text on this FDA row.
Phenoxybenzamine Hydrochloride Capsule: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Phenoxybenzamine Hydrochloride Capsule
- Manufacturer
- Advanz Pharma (US) Corp.
- Dosage Form
- Capsule
- Presentation
- Dibenzyline, Capsule, 10 mg (NDC 59212-001-02)
- Package NDC
- 59212-001-02
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Dec 1, 2025
- Last Updated
- Dec 1, 2025
- Therapeutic Category
- Cardiovascular
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Nearby, Other Phenoxybenzamine Shortage Records
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.